文献速递妇科

卵巢癌患者采用降阶梯预防策略后术后血栓事件的发生率:一项回顾性队列研究

Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study.
PubMed 文献 · Gynecol Oncol · 2022-02-23

该回顾性队列研究纳入2007年1月至2019年5月单中心799例卵巢癌减瘤手术患者,评估降阶梯预防策略下术后6个月内血栓事件发生率。结果显示血栓事件发生率为3.5%(28例),年龄、BMI和手术时长是独立危险因素,血栓事件为总生存的独立预后因素(HR 2.17,95%CI 1.16-4.1)。年龄<57岁且BMI<21的低危组172例中仅1例(0.58%)发生血栓事件,作者认为该低危人群可考虑降阶梯预防策略。

要点

  • 减瘤术后6个月内血栓事件发生率为3.5%(28/799),包括肺血栓栓塞症11例、深静脉血栓10例和其他血栓事件7例。
  • 年龄、BMI和手术时长是与血栓事件相关的独立危险因素,血栓事件为总生存的独立预后因素(HR 2.17,95%CI 1.16-4.1)。
  • 年龄<57岁且BMI<21的低危组172例中仅1例(0.58%)发生血栓事件,作者认为该人群可考虑降阶梯预防策略。

核心结论

  • 本队列中血栓事件发生率较低,作者认为年轻(年龄<57岁)且瘦(BMI<21)的患者可考虑降阶梯预防策略。

研究设计与样本

  • 回顾性队列研究,纳入2007年1月至2019年5月单中心接受卵巢癌减瘤手术的患者,排除基线或新辅助化疗期间诊断血栓栓塞的13例后,共分析799例。

主要发现

  • 自2009年本院引入药物预防以来,482例(60%)接受低分子肝素皮下注射5天联合机械预防,317例(40%)仅接受机械预防。
  • 减瘤手术后血栓事件发生于28例(3.5%),包括肺血栓栓塞症(n=11)、深静脉血栓(n=10)和其他血栓事件(n=7)。
  • 多变量分析确定年龄、体重指数(BMI)和手术时长为与血栓事件相关的独立危险因素。
  • 血栓事件为总生存的独立预后因素(HR 2.17,95%CI 1.16-4.1)。
  • 术前可识别危险因素的截断值分析显示,年龄<57岁且BMI<21有助于定义低危组;172例低危患者中1例(0.58%)发生血栓事件。

关键数值与推荐

  • 低危组定义为年龄<57岁且BMI<21,该组172例中1例(0.58%)发生血栓事件。

临床怎么用

  • 作者认为,对于年轻(年龄<57岁)且瘦(BMI<21)的患者,可考虑降阶梯预防策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to determine the incidence of thrombotic events in ovarian cancer patients following a de-escalated prophylactic strategy and to stratify risk groups. METHODS: We reviewed the records of patients who underwent debulking surgery for ovarian cancer at a single institution between January 2007 and May 2019. We identified clinically diagnosed and radiologically confirmed cases of thrombotic events-classified as pulmonary thromboembolism (PE), deep vein thrombosis (DVT), and other thrombotic events-within 6 months of debulking surgery. RESULTS: After excluding 13 patients diagnosed with thromboembolism at the baseline or during neoadjuvant chemotherapy, 799 were analyzed. Since the introduction of medical prophylaxis at our institution in 2009, 482 patients (60%) received medical prophylaxis with subcutaneous injection of low molecular weight heparin for 5 days with mechanical prophylaxis, whereas 317 (40%) received mechanical prophylaxis only. After debulking surgery, thrombotic events occurred in 28 patients (3.5%) including PE (n = 11), DVT (n = 10), and other thrombotic events (n = 7). Multivariable analysis identified age, body mass index (BMI), and operative duration as independent risk factors associated with thrombotic events. A thrombotic event was an independent prognostic factor for overall survival (HR 2.17, 95% CI 1.16-4.1). A cut-off analysis for pre-operative identifiable risk factors showed age < 57 years and BMI < 21 could help define low-risk groups. One patient from 172 low-risk patients (0.58%) experienced a thrombotic event. CONCLUSIONS: The thrombotic event incidence was low in our cohort. A de-escalated prophylaxis strategy may be considered in young (age < 57 years) and lean (BMI < 21) patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim YN, Kim JC, Chung YS, et al. Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study. Gynecol Oncol. 2022. PMID: 35216810. doi:10.1016/j.ygyno.2022.02.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。